
Browsing restrictions can be lifted for a fee.
China Development Financial Holding Corporation provides life insurance, commercial banking, securities, venture capital, and private equity services in Taiwan and internationally. The company accepts various deposits, including time, savings, demand, checking, and certificates of deposit; and offers various loans, such as working capital loans, structured and project financing, domestic and international joint loans, consumer and mortgage loans, personal housing loans, credit loans, and cash cards, as well as credit cards and supply chain payment services. It also offers corporate, consumer, and digital banking services; provides foreign exchange, cash management, and trade finance; and offers mutual funds, bonds, stocks, and trust services. In addition, the company provides financial consulting, wealth management, leasing, futures and options investment, and settlement services; and life/property insurance brokerage services. Further, it offers underwriting, financial transactions, and financial investments services, as well as engages in the sale of financial products. Additionally, the company offers cash and derivative financial products including currency, foreign exchange, interest rate, commodity, and equity markets; and life insurance products, such as individual traditional life, individual injury, individual health, group insurance, annuities, and investment-linked insurance products. China Development Financial Holding Corporation was founded in 1959 and is headquartered in Taipei, Taiwan.
2883
凱基金
-7.29%
(-0.07)
The most recent financial report for 凱基金 (2883) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 2883's short-term business performance and financial health. For the latest updates on 2883's earnings releases, visit this page regularly.
According to historical valuation range analysis, 凱基金 (2883)'s current price-to-earnings (P/E) ratio is 9.94, placing it in the Watch zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning optimistic. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.
In the latest financial report, 凱基金 (2883) announced revenue of 10.07B, with a Year-Over-Year growth rate of -58.74%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
At the end of the period, 凱基金 (2883) held Total Cash and Cash Equivalents of 63.29B, accounting for 0.02 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
According to the past four quarterly reports, 凱基金 (2883)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 0.8. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.